海外の治験の状況「前立腺癌」での検索結果
403件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
- Metastatic Castrate Resistant Prostate Cancer
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Estonia, France, Germany, Greece, India, Ireland, Italy, Latvia, Lebanon, Lithuania, Mexico, Netherlands, New Zealand, Norway, Panama, Peru, Poland, Republic of Korea, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States of America
- 2012-07-16
Recruiting
- The safety and efficacy of Irreversible Electroporation for the ablation of prostate cancer assessed by procedural related side effects and post prostatectomy histology: A pilot study
- Prostate cancer
- Australia
- 2012-05-16
Not Recruiting
- A Phase III, Randomised, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Once-daily Orally Administered ZD4054 (Zibotentan) 10 mg in Non-metastatic Hormone-resistant Prostate Cancer Patients
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Finland, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Mexico, Netherlands, Norway, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, South Africa, Spain, Sweden, Switzerland, Taiwan, Province of China, Turkey, United Kingdom, United States
- 2012-04-30
Not Recruiting
- REGISTRY OF TREATMENT PATTERNS IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) WITH PROGRESSION DURING OR AFTER DOCETAXEL-BASED REGIMEN
- metastatic castration registant prostate cancer
- Africa, Asia(except Japan), Europe, Japan, South America
- 2012-04-12
Not recruiting
- A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100
- Castration-Resistant Prostate Cancer (CRPC);Castration-Resistant Prostate Cancer (CRPC);Castration-Resistant Prostate Cancer (CRPC)
- Moldova, Republic of, South Africa, United States
- 2012-02-08
Not recruiting
- Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate Cancer
- Prostate Cancer
- Australia
- 2013-11-25
Not Recruiting
- Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, Mexico, Netherlands, Norway, Poland, Puerto Rico, Romania, Spain, Sweden, Turkey, United Kingdom, United States
- 2013-11-20
Recruiting
- An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Mexico, Spain, United States
- 2017-11-08
Recruiting
- A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
- Metastatic Castration Resistant Prostate Cancer
- Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Spain, United Kingdom, United States
- 2016-10-24
Not recruiting
- Phase II pre-operative study of Androgen Deprivation Therapy (Degarelix) and Erdafitinib in high-risk localized prostate cancer.
- Prostate Cancer
- Australia
- 2018-06-26